The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Will Be The Estimated Market Size Of The Stem Cell Therapy For Multiple Sclerosis Market By 2030?
The stem cell therapy for multiple sclerosis market has shown considerable expansion in recent years. This market is expected to expand from $1.82 billion in 2025 to $2.05 billion in 2026, growing at a compound annual growth rate (CAGR) of 12.4%. The historical increase in this market can be attributed to progress in multiple sclerosis treatment research, a rise in the diagnosis rates of autoimmune disorders, the expansion of stem cell clinical trials, enhancements in patient selection protocols, and the growing accessibility of specialized neurology centers.
The stem cell therapy market for multiple sclerosis is projected to experience substantial growth in the upcoming years. It is anticipated to reach $3.24 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This expansion during the forecast period is primarily driven by the increasing availability of long-term efficacy data for stem cell treatments, a growing demand for disease-modifying therapies, the widening of personalized neurology care, escalating investments in neuro-regenerative research, and enhanced collaboration between hospitals and research institutions. Key trends expected over the forecast period involve the rising adoption of autologous hematopoietic stem cell transplants, an increasing focus on immune system reset therapies, the broader application of mesenchymal stem cells, the expanded use of targeted delivery methods, and improved clinical monitoring alongside outcome tracking.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30409&type=smp
What Major Growth Factors Are Impacting The Stem Cell Therapy For Multiple Sclerosis Market?
The growing occurrence of multiple sclerosis (MS) is anticipated to play a major role in expanding the stem cell therapy for multiple sclerosis market in the future. MS is a long-term autoimmune disorder that impacts the central nervous system by harming the myelin sheath that protects nerve fibers, disrupting communication between the brain and body and causing issues like fatigue, muscle weakness, and vision difficulties. This rise in MS cases is mainly due to better diagnostic tools, as developments in medical imaging and greater public awareness allow for more precise and earlier detection, leading to higher reported figures. Stem cell therapy for multiple sclerosis works by repairing damaged myelin, adjusting irregular immune responses, and fostering nerve cell regrowth, which helps alleviate symptoms and potentially slow the disease’s advancement. For example, in May 2024, a report from the MS Trust, a UK-based organization, indicated that around 2.9 million people globally suffer from multiple sclerosis, with over 150,000 individuals living with the condition in the UK. Consequently, the increasing prevalence of multiple sclerosis is expected to propel the growth of the stem cell therapy for multiple sclerosis market.
How Is The Stem Cell Therapy For Multiple Sclerosis Market Distributed Across Key Segments?
The stem cell therapy for multiple sclerosis market covered in this report is segmented –
1) By Type Of Stem Cell: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells, Hematopoietic Stem Cells
2) By Treatment Approach: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy
3) By Delivery Method: Intravenous Injection, Intrathecal Injection, Direct Intraspinal Administration
4) By Application: Relapsing-Remitting Multiple Sclerosis (RRMS), Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Progressive Relapsing Multiple Sclerosis (PRMS)
5) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Embryonic Stem Cells: Inner Cell Mass Cells, Blastocyst Derived Cells, Totipotent Stem Cells
2) By Adult Stem Cells: Bone Marrow Stem Cells, Neural Stem Cells, Tissue Specific Stem Cells
3) By Induced Pluripotent Stem Cells: Reprogrammed Somatic Cells, Patient Derived Cells
4) By Mesenchymal Stem Cells: Adipose Derived Stem Cells, Umbilical Cord Derived Stem Cells, Bone Marrow Derived Stem Cells
5) By Hematopoietic Stem Cells: Peripheral Blood Stem Cells, Bone Marrow Stem Cells, Umbilical Cord Blood Stem Cells
What Trends Are Driving Changes In The Stem Cell Therapy For Multiple Sclerosis Market?
Companies operating significantly within the stem cell therapy for infertility market are concentrating on advancements in stem cell technologies, such as induced pluripotent stem cells (iPSCs), with the goal of improving personalized regenerative treatments, enhancing patient-specific outcomes, and expanding the array of treatable reproductive conditions. Induced pluripotent stem cells are adult somatic cells that have undergone genetic reprogramming to achieve an embryonic-like pluripotent state, allowing them to differentiate into nearly any cell type in the body. For example, in January 2025, Gameto Inc., a US-based biotechnology company, launched a crucial Phase III clinical trial for Fertilo, its iPSC-derived fertility therapy, following Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA). This trial, involving approximately 15 sites across the U.S., aims to assess egg maturation outside the body utilizing engineered ovarian support cells, potentially shortening IVF cycles and reducing hormonal stimulation by up to 80%. If successful, this would be the first late-stage clinical program for an in-vitro matured egg therapy derived from induced pluripotent stem cells in the treatment of infertility.
Who Are The Prominent Players Across The Stem Cell Therapy For Multiple Sclerosis Market?
Major companies operating in the stem cell therapy for multiple sclerosis market are Sana Biotechnology Inc., Century Therapeutics Inc., Reelabs Private Limited, PlacidWay LLC, MedAccess Guarantee Ltd, Celltex Therapeutics Corporation, CELLTEX THERAPEUTICS CORP, BrainStorm Cell Therapeutics Ltd., Athersys Inc., Advancells Dermaceuticals Private Limited, ImStem Biotechnology Inc., NeuroGenesis Bio Inc., Stem Cell Medicine Ltd., Biotherapy International, R3 Stem Cell, Hope Biosciences LLC, FibroBiologics Inc., Global Institute of Stem Cell Therapy and Research Inc., ProgenCell, Stemwell
Access The Complete Stem Cell Therapy For Multiple Sclerosis Market Report:
Which Region Is The Dominant Market In The Stem Cell Therapy For Multiple Sclerosis Market?
North America was the largest region in the stem cell therapy for multiple sclerosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell therapy for multiple sclerosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Stem Cell Therapy For Multiple Sclerosis Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=30409&type=smp
Browse Through More Reports Similar to the Global Stem Cell Therapy For Multiple Sclerosis Market 2026, By The Business Research Company
Human Embryonic Stem Cells Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/human-embryonic-stem-cells-global-market-report
Stem Cell Manufacturing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report
Autologous Stem Cell And Non Stem Cell Based Therapies Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model